Steve Cohen: portfolio of Point72 Asset Management

Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.

Source: 13F filing with the US Securities and Exchange Commission dated Nov 14, 2022. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q3 2022. Go to the latest filing (Q3 2026)

22.6B USDQ3 2022
Total value of stock positions
22.6B USD
Positions
961
Share of the ten largest
11.9%

The ten largest positions Q3 2022

  1. Biogen 2.0%▲ +268.1%
  2. T-Mobile US 1.4%▼ −20.0%
  3. Alibaba Group (ADR) 1.2%▲ +489.7%
  4. AstraZeneca 1.2%▲ +144.0%
  5. Meta Platforms 1.2%▲ +89.3%
  6. Fidelity National Information Services 1.1%▲ +67.8%
  7. Palo Alto Networks 1.0%▲ +112.1%
  8. Arista Networks 1.0%▲ +4.6%
  9. Microsoft 1.0%▲ +148.0%
  10. Amazon 0.9%▲ +40.0%
Total value of stock positions per quarter, Q2 2014 to Q3 2026 (peak 62.9B USD).
Choose a quarter (50 filings)

All positions Q3 2022

Positions Q3 2022 per 13F filing, 50 of 961
Symbol Weight Shares Reported value Change Held since
Bunge Limited 0.2% 556,300 45.9M USD +563.1% increased Q2 2014 or earlier 34 quarters
CME CME Group < 0.1% 82,379 14.6M USD −30.1% reduced Q2 2014 or earlier 34 quarters
Xenon Pharmaceuticals Inc 0.3% 1,640,072 59.2M USD +81.9% increased Q1 2015 31 quarters
Select Sector SPDR TR < 0.1% 240,000 7.3M USD unchanged Q4 2016 24 quarters
AMZN Amazon 0.9% 1,837,862 207.7M USD +40.0% increased Q1 2017 23 quarters
PANW Palo Alto Networks 1.0% 1,413,942 231.6M USD +112.1% increasedafter 3:1 stock split Q1 2018 19 quarters
Sanofi 0.3% 1,727,777 65.7M USD +446.8% increased Q1 2018 19 quarters
BKNG Booking Holdings 0.2% 25,782 42.4M USD −57.8% reduced Q1 2018 19 quarters
Alaska Air Group Inc < 0.1% 550,500 21.6M USD −35.1% reduced Q2 2018 18 quarters
LVS Las Vegas Sands 0.4% 2,199,307 82.5M USD +47.2% increased Q3 2018 17 quarters
Repligen Corp 0.3% 307,104 57.5M USD −38.9% reduced Q3 2018 17 quarters
GPN Global Payments 0.2% 317,250 34.3M USD −4.1% reduced Q3 2018 17 quarters
Insmed Inc 0.1% 1,541,474 33.2M USD −7.2% reduced Q3 2018 17 quarters
American Finl Group Inc Ohio 0.3% 633,459 77.9M USD +84.3% increased Q4 2018 16 quarters
Enerplus Corp 0.1% 2,318,556 32.8M USD −15.7% reduced Q4 2018 16 quarters
Bread Financial Holdings Inc < 0.1% 249,910 7.9M USD −19.2% reduced Q4 2018 16 quarters
FIS Fidelity National Information Services 1.1% 3,331,045 251.7M USD +67.8% increased Q1 2019 15 quarters
Select Sector SPDR TR 0.7% 2,108,000 151.8M USD +51.7% increased Q1 2019 15 quarters
Childrens Pl Inc New < 0.1% 209,323 6.5M USD +363.1% increased Q1 2019 15 quarters
JBL Jabil 0.5% 2,063,000 119.1M USD +4.1% increased Q2 2019 14 quarters
Performance Food Group Co < 0.1% 399,362 17.2M USD −79.8% reduced Q2 2019 14 quarters
Cytokinetics Inc < 0.1% 32,000 1.6M USD +63.0% increased Q2 2019 14 quarters
DD DuPont < 0.1% 5,237 264.0K USD −98.8% reduced Q2 2019 14 quarters
TRGP Targa Resources 0.1% 515,900 31.1M USD +79.5% increased Q3 2019 13 quarters
Affimed N V < 0.1% 5,386,520 11.1M USD −16.5% reduced Q3 2019 13 quarters
Bicycle Therapeutics PLC 0.1% 1,255,418 29.2M USD −13.1% reduced Q4 2019 12 quarters
Neoleukin Therapeutics Inc < 0.1% 2,064,222 1.3M USD +43.6% increased Q4 2019 12 quarters
Ally Finl Inc < 0.1% 1,300 36.0K USD −98.1% reduced Q4 2019 12 quarters
AZN AstraZeneca 1.2% 4,811,660 263.9M USD +144.0% increased Q1 2020 11 quarters
MSFT Microsoft 1.0% 957,370 223.0M USD +148.0% increased Q1 2020 11 quarters
DHR Danaher Corporation 0.3% 285,623 73.8M USD +113.1% increased Q1 2020 11 quarters
Avantor Inc 0.2% 2,345,788 46.0M USD −45.6% reduced Q1 2020 11 quarters
AZO AutoZone 0.2% 18,553 39.7M USD −66.7% reduced Q1 2020 11 quarters
Texas Roadhouse Inc 0.1% 357,415 31.2M USD −21.8% reduced Q1 2020 11 quarters
Equitable HLDGS Inc 0.1% 937,461 24.7M USD −24.2% reduced Q1 2020 11 quarters
Exelixis Inc < 0.1% 923,700 14.5M USD +80.2% increased Q1 2020 11 quarters
Ngm Biopharmaceuticals Inc < 0.1% 362,900 4.7M USD −72.5% reduced Q1 2020 11 quarters
Applied Therapeutics Inc < 0.1% 1,719,938 1.6M USD −39.3% reduced Q1 2020 11 quarters
Ishares TR < 0.1% 20,000 986.0K USD −50.0% reduced Q1 2020 11 quarters
TMUS T-Mobile US 1.4% 2,283,835 306.4M USD −20.0% reduced Q2 2020 10 quarters
META Meta Platforms 1.2% 1,932,078 262.1M USD +89.3% increased Q2 2020 10 quarters
ADI Analog Devices 0.9% 1,422,672 198.2M USD +148.9% increased Q2 2020 10 quarters
Bill Com HLDGS Inc 0.6% 1,071,738 141.9M USD −15.2% reduced Q2 2020 10 quarters
GM General Motors 0.6% 4,130,470 132.5M USD +72.6% increased Q2 2020 10 quarters
Krystal Biotech Inc 0.4% 1,258,505 87.7M USD −20.1% reduced Q2 2020 10 quarters
Uniqure NV 0.4% 4,259,886 79.9M USD +11.5% increased Q2 2020 10 quarters
CB Chubb Limited 0.3% 423,191 77.0M USD +99.0% increased Q2 2020 10 quarters
Spirit Aerosystems HLDGS Inc 0.2% 2,455,963 53.8M USD −8.2% reduced Q2 2020 10 quarters
MRK Merck & Co. 0.2% 594,800 51.2M USD −50.3% reduced Q2 2020 10 quarters
Radnet Inc 0.2% 1,811,974 36.9M USD +22.0% increased Q2 2020 10 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Show more (up to 500) Shown: the 50 longest-held of 961 positions.

Plus 367 option positions, value of the underlying shares as reported 2.0B USD – not included in the weights.

The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.

  • SPDR S&P 500 ETF TR Put 328.4M USD
  • SPDR S&P 500 ETF TR Call 103.3M USD
  • Invesco Db Multi-Sector Comm Call 90.1M USD
  • Gsk PLC Call 72.1M USD
  • Ishares TR Put 58.3M USD
  • Select Sector SPDR TR Call 53.3M USD
  • Medical Pptys Trust Inc Put 51.3M USD
  • Apple Inc. Put 39.0M USD
  • Microsoft Put 32.1M USD
  • Sanofi Call 28.5M USD
Plus 44 positions in convertible bonds and bonds worth 400.1M USD as reported – not included in the weights.

Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.

  • Novavax Inc principal 38.9M USD 38.2M USD
  • Dish Network Corporation principal 37.0M USD 24.3M USD
  • Royal Caribbean Group principal 21.4M USD 20.2M USD
  • Spotify USA Inc principal 24.5M USD 19.4M USD
  • Ford Mtr Co Del principal 20.8M USD 19.1M USD
  • Avalara Inc principal 18.5M USD 17.9M USD
  • Docusign Inc principal 17.5M USD 16.4M USD
  • Ringcentral Inc principal 18.2M USD 15.3M USD
  • Wayfair Inc principal 18.1M USD 15.1M USD
  • Sarepta Therapeutics Inc principal 9.0M USD 15.0M USD

Breakdown by sector

  • Technology 12.2%
  • Consumer Discretionary 7.6%
  • Health Care 7.5%
  • Financials 6.1%
  • Industrials 4.0%
  • Communication Services 3.8%
  • Utilities 3.2%
  • Consumer Staples 2.5%
  • Energy 2.4%
  • Materials 1.8%
  • Real Estate 1.2%
  • not in our coverage 47.6%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close